Atrial fibrillation is not associated with increased risk of venous thromboembolism: Results from ARAPACIS study

Thromb Haemost 2015; 114(03): 655
DOI: 10.1160/TH15-02-0101

Letters to the Editor

Schattauer GmbH

Stefania Basili

¹I Clinica Medica, Sapienza University Of Rome, Italy

,

Marco Proietti

¹I Clinica Medica, Sapienza University Of Rome, Italy

²University of Birmingham, Centre for Cardiovascular Sciences, City Hospital, Birmingham, UK

,

Francesco Perticone

³University of Catanzaro, Catanzaro, Italy

,

Gino Roberto Corazza

⁴First Department of Internal Medicine, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy

,

Francesco Violi

¹I Clinica Medica, Sapienza University Of Rome, Italy

,

the ARAPACIS Study Investigators

References
1 Wang CC, Lin CL, Wang GJ. et al. Atrial fibrillation associated with increased risk of venous thromboembolism. A population-based cohort study. Thromb Haemost 2015; 113: 185-192.
2 Violi F, Daví G, Hiatt W. et al. Prevalence of peripheral artery disease by abnormal ankle-brachial index in atrial fibrillation: implications for risk and therapy. J Am Coll Cardiol 2013; 62: 2255-2256.
3 Heit JA. Venous thromboembolism: disease burden, outcomes and risk factors. J Thromb Hae-most 2005; 03: 1611-1617.
4 Raparelli V, Proietti M, Buttà C. et al. Medication prescription and adherence disparities in non valvular atrial fibrillation patients: an Italian portrait from the ARAPACIS study. Intern Emerg Med 2014; 09: 861-870.
5 Di Nisio M, Porreca E, Otten HM. et al. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy. Cochrane Database Syst Rev 2014; 08: CD008500.